Cargando…
Open‐label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin‐naïve Asian patients with type 2 diabetes
INTRODUCTION: The present phase 3, randomized, open‐label study compared the efficacy and safety of basal insulin peglispro with insulin glargine after 26 weeks of treatment when added to oral antihyperglycemic medications in insulin‐naïve Asian patients with type 2 diabetes. MATERIALS AND METHODS:...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754544/ https://www.ncbi.nlm.nih.gov/pubmed/28371567 http://dx.doi.org/10.1111/jdi.12667 |